These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 35635171)

  • 21. Assessing the clinical value of faecal bile acid profiling to predict recurrence in primary Clostridioides difficile infection.
    Mullish BH; Martinez-Gili L; Chekmeneva E; Correia GDS; Lewis MR; Horneffer-Van Der Sluis V; Roberts LA; McDonald JAK; Pechlivanis A; Walters JRF; McClure EL; Marchesi JR; Allegretti JR
    Aliment Pharmacol Ther; 2022 Dec; 56(11-12):1556-1569. PubMed ID: 36250604
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bile acid-independent protection against Clostridioides difficile infection.
    Aguirre AM; Yalcinkaya N; Wu Q; Swennes A; Tessier ME; Roberts P; Miyajima F; Savidge T; Sorg JA
    PLoS Pathog; 2021 Oct; 17(10):e1010015. PubMed ID: 34665847
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microbiota transplantation restores normal fecal bile acid composition in recurrent Clostridium difficile infection.
    Weingarden AR; Chen C; Bobr A; Yao D; Lu Y; Nelson VM; Sadowsky MJ; Khoruts A
    Am J Physiol Gastrointest Liver Physiol; 2014 Feb; 306(4):G310-9. PubMed ID: 24284963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tauroursodeoxycholic Acid Inhibits Clostridioides difficile Toxin-Induced Apoptosis.
    Pike CM; Tam J; Melnyk RA; Theriot CM
    Infect Immun; 2022 Aug; 90(8):e0015322. PubMed ID: 35862710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dietary-protein sources modulate host susceptibility to Clostridioides difficile infection through the gut microbiota.
    Yakabe K; Higashi S; Akiyama M; Mori H; Murakami T; Toyoda A; Sugiyama Y; Kishino S; Okano K; Hirayama A; Gotoh A; Li S; Mori T; Katayama T; Ogawa J; Fukuda S; Hase K; Kim YG
    Cell Rep; 2022 Sep; 40(11):111332. PubMed ID: 36103838
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Food for thought-The link between Clostridioides difficile metabolism and pathogenesis.
    Marshall A; McGrath JW; Graham R; McMullan G
    PLoS Pathog; 2023 Jan; 19(1):e1011034. PubMed ID: 36602960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epigallocatechin-3-Gallate Improves Intestinal Gut Microbiota Homeostasis and Ameliorates
    Wu Z; Shen J; Xu Q; Xiang Q; Chen Y; Lv L; Zheng B; Wang Q; Wang S; Li L
    Nutrients; 2022 Sep; 14(18):. PubMed ID: 36145133
    [No Abstract]   [Full Text] [Related]  

  • 28. Bile acids and microbes in metabolic disease.
    Sah DK; Arjunan A; Park SY; Jung YD
    World J Gastroenterol; 2022 Dec; 28(48):6846-6866. PubMed ID: 36632317
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological and Metabolic Significance of Bile Acids in Retinal Diseases.
    Win A; Delgado A; Jadeja RN; Martin PM; Bartoli M; Thounaojam MC
    Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33669313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intestinal bile acids directly modulate the structure and function of
    Tam J; Icho S; Utama E; Orrell KE; Gómez-Biagi RF; Theriot CM; Kroh HK; Rutherford SA; Lacy DB; Melnyk RA
    Proc Natl Acad Sci U S A; 2020 Mar; 117(12):6792-6800. PubMed ID: 32152097
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intestinal Inflammation and Altered Gut Microbiota Associated with Inflammatory Bowel Disease Render Mice Susceptible to Clostridioides difficile Colonization and Infection.
    Abernathy-Close L; Barron MR; George JM; Dieterle MG; Vendrov KC; Bergin IL; Young VB
    mBio; 2021 Jun; 12(3):e0273320. PubMed ID: 34126769
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ridinilazole, a narrow spectrum antibiotic for treatment of
    Qian X; Yanagi K; Kane AV; Alden N; Lei M; Snydman DR; Vickers RJ; Lee K; Thorpe CM
    Am J Physiol Gastrointest Liver Physiol; 2020 Aug; 319(2):G227-G237. PubMed ID: 32597706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effective fecal microbiota transplantation for recurrent Clostridioides difficile infection in humans is associated with increased signalling in the bile acid-farnesoid X receptor-fibroblast growth factor pathway.
    Monaghan T; Mullish BH; Patterson J; Wong GK; Marchesi JR; Xu H; Jilani T; Kao D
    Gut Microbes; 2019; 10(2):142-148. PubMed ID: 30183484
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bile Acids as Key Modulators of the Brain-Gut-Microbiota Axis in Alzheimer's Disease.
    Mulak A
    J Alzheimers Dis; 2021; 84(2):461-477. PubMed ID: 34569953
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microbially catalyzed conjugation of GABA and tyramine to bile acids.
    Mullowney MW; Fiebig A; Schnizlein MK; McMillin M; Rose AR; Koval J; Rubin D; Dalal S; Sogin ML; Chang EB; Sidebottom AM; Crosson S
    J Bacteriol; 2024 Jan; 206(1):e0042623. PubMed ID: 38174933
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The molecular insights of bile acid homeostasis in host diseases.
    Zhang J; Lyu A; Wang C
    Life Sci; 2023 Oct; 330():121919. PubMed ID: 37422071
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of short-chain fatty acids in Clostridioides difficile infection: A review.
    Ouyang ZR; Niu XR; Wang WG; Zhao JH
    Anaerobe; 2022 Jun; 75():102585. PubMed ID: 35545183
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Initial Gut Microbiota and Response to Antibiotic Perturbation Influence Clostridioides difficile Clearance in Mice.
    Tomkovich S; Stough JMA; Bishop L; Schloss PD
    mSphere; 2020 Oct; 5(5):. PubMed ID: 33087520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Destination and Specific Impact of Different Bile Acids in the Intestinal Pathogen
    Metzendorf NG; Lange LM; Lainer N; Schlüter R; Dittmann S; Paul LS; Troitzsch D; Sievers S
    Front Microbiol; 2022; 13():814692. PubMed ID: 35401433
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clostridioides difficile and the Microbiota Early in Life.
    Semon AK; Keenan O; Zackular JP
    J Pediatric Infect Dis Soc; 2021 Nov; 10(Supplement_3):S3-S7. PubMed ID: 34791400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.